Abstracts

956 – NAT-2 Polymorphism and Risk of Antituberculosis-Induced Hepatotoxicity in Thai People With HIV

Background The NAT2 slow acetylator phenotype is associated with a higher risk of isoniazid-induced hepatitis. There is a high prevalence of slow acetylators in the Thai population. This study aimed to explore the link between NAT2 genotypes and hepatitis risk in Thai people living with HIV (PLWH) after initiating isoniazid containing regimens for TB preventive therapy (TPT) or TB treatment.  Methods A…

963 – Healthcare Worker- Versus Self-Collected Tongue Swabs for Mycobacterium tuberculosis Detection

Background Most studies have focused on either healthcare worker collected (HCWC) or self-collected (SC) tongue swabs (TS) for detecting Mycobacterium tuberculosis, but rarely on both. We assessed this, on TS collected from the same participant, using the Xpert MTB/RIF Ultra (Ultra) (Cepheid, Sunnyvale, CA, USA) along with participant acceptability of the collection procedure. Methods In…

862 – Durability of Semaglutide Effects After Drug Discontinuation in HIV-Associated Lipohypertrophy

Background Lipohypertrophy (central adipose tissue (AT) accumulation) and AT abnormalities are common in people with HIV (PWH) and are key drivers of cardiometabolic co-morbidities. In a recent randomized, double-blind, placebo-controlled phase 2b clinical trial, we observed significant effects of the glucagon-like peptide-1 receptor agonist (GLP-1 RA), semaglutide, over 32 weeks on key outcome measures, including reductions…

938 – Exploring the Molecular Pathways of Long COVID With Post-Exertional Fatigue: A Multiomic Approach

Background Post-exertional malaise (PEM) is a disabling condition characterized by worsened symptoms after mental or physical exertion, commonly seen in Long-COVID (LC). While its underlying pathophysiology is unclear, potential mechanisms include oxidative stress, and metabolic derangements. We conducted a multiomic analysis to identify changes in energy metabolism, immune function and cellular stress responses in patients with…

931 – Immune and Virologic Trajectories 1.5 Years Before and After COVID-19 in an Early-Treated HIV Cohort

Background SARS-CoV-2 infection can be associated with immunologic dysfunction and might serve as a ‘second hit’ to immune function in people with HIV (PWH) despite suppression with antiretroviral therapy (ART). We leveraged the RV254 Thai cohort to examine the trajectory of immunologic and virologic parameters 1.5 years pre- and post-COVID-19 in PWH on stable ART initiated…

932 – Longitudinal Changes in Arterial Stiffness and Inflammation From Pre- to Post-COVID-19 Infection

Background We have previously shown in cross-sectional studies that COVID-19 infection was associated with arterial stiffness and increased oxidized LDL (oxLDL).  In this study, we assess changes in these cardiovascular parameters after COVID infection in a group of individuals who have documented pre-COVID assessments.  Having pre-COVID assessments has been a limitation of current studies. Methods…

716 – Tracking Key Remdesivir Resistance Mutations in SARS-CoV-2 Using GISAID Data (2020-2024)

Background The emergence of remdesivir (RDV) resistance mutations poses a potential challenge in treating SARS-CoV-2 infections, especially as the virus continues to evolve globally. GISAID data provides an extensive resource for tracking such mutations. This study aims to investigate the temporal trends and incidence rates of RDV resistance-associated mutations, specifically those conferring a >2.5-fold reduction…